AI Governance
AI Agent Governance Scenarios, Part 2: The "Helpful Trend Analysis" Agent
Six months after deployment, a deviation trend-analysis agent is now cited as evidence in CAPA closures. Is that still appropriate use, and what changed without anyone noticing?
This is the second in a five-part series of practical AI-governance scenarios for quality professionals.
The scenario
Six months ago, a quality team implemented an AI agent to assist with deviation trend analysis across deviation reports, CAPA investigations, environmental monitoring events, and batch record deviations. Its original purpose was to highlight possible patterns for QA to investigate further, producing a monthly trend summary for the quality management review meeting.
Over time, reliance has grown quietly: the trend report is now used directly in quality review meetings; investigators reference it to support root-cause conclusions; a recent CAPA closure cited the AI report as evidence that "no recurring trend exists"; and the report is now routinely attached to quality review documentation.
Is this still appropriate use? What questions would you ask, what controls should be reviewed, and what risks may have emerged over time?
The subtle issues hidden in this drift
The report is now used directly in quality review meetings. Output originally intended as a supplementary investigation tool is being treated as an authoritative source for critical decisions, bypassing the human oversight and critical evaluation GxP requires. The agent must remain a governed assistant, not an autonomous decision authority, and QA personnel need to independently evaluate evidence rather than accepting AI-generated conclusions.
CAPA closures cite the AI report as conclusive evidence. Investigators citing "no recurring trend exists" as a closure justification undermines the thoroughness of human investigation and relies on the agent for a determination it was never designed to make. Its role was explicitly to detect patterns, not to make compliance determinations — pattern identification is not the same capability as a defensible compliance conclusion.
The agent's role expanded without formal review. The organisation allowed scope to broaden gradually, with no formal assessment or documentation — an informal expansion that circumvents the QMS's own change control procedures. Any expansion of intended use requires a formal, documented review, not accretion by habit.
Investigators increasingly rely on the trend summary. There is a real risk that human reviewers are now confirming the agent's output rather than conducting independent evaluation, reducing human vigilance and risking oversight of details the agent may miss or misinterpret.
The report may not show which records were analysed. Without visibility into which specific deviation reports or CAPAs contributed to a trend, the integrity and auditability of the analysis is compromised — QA needs to be able to trace conclusions back to the specific records analysed.
The agent aggregates multiple record types. Combining deviation reports, CAPAs, and investigations for analysis is potentially efficient, but introduces risk of incomplete datasets, draft records, or omitted relevant events feeding a flawed trend.
Six months, no reassessment. Despite expanded usage over an extended period, there has been no structured, formal review of the agent's continued suitability or its impact on the quality management system — a significant governance gap in its own right.
What this scenario teaches
AI risk often increases gradually, through small behavioural changes rather than a single design flaw. The agent itself may be technically unchanged, but its role in decision-making has evolved — that is a classic GMP governance issue, and it is exactly the kind of drift that periodic review, not a one-time validation, is designed to catch.